The Senegalese Antiretroviral Drug Access Initiative. An economic social behavioural and biomedical analysis.

Abstract

This work presents an analysis of the preliminary results of the Senegalese Antiretroviral Drug Access Initiative (ISAARV) and of its evolution over its first three years. A general introduction to ISAARV (Ibra Ndoye et al.) is followed by four parts that explore the essential questions of treatment access adherence therapeutic efficacy and the impact of this treatment programme on the Senegalese health-care system. (excerpt)